L
The startup develops a healthcare platform focused on drug discovery for subarachnoid hemorrhage (SAH), targeting the creation of effective treatments for this rare and life-threatening condition. By utilizing advanced methodologies in medicinal chemistry and pharmacology, the platform aims to address the significant unmet medical need for successful medications in this area.
Palo Alto, United States
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops a healthcare platform focused on drug discovery for subarachnoid hemorrhage (SAH), targeting the creation of effective treatments for this rare and life-threatening condition. By utilizing advanced methodologies in medicinal chemistry and pharmacology, the platform aims to address the significant unmet medical need for successful medications in this area.